Chengwei Peng
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Cancer-related molecular mechanisms research
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 3
- CAR-T cell therapy research 2
-
- Protein Degradation and Inhibitors 3
- Melanoma and MAPK Pathways 2
- Co-authors
- Jeffrey A. Sosman (5 shared papers)Douglas B. Johnson (5 shared papers)Avani Verma (1 shared paper)James A. McNew (1 shared paper)Joseph E. Faust (1 shared paper)Deirdre Jill Cohen (1 shared paper)Zhe Su (1 shared paper)Chuanqing Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Gene (1 paper)Traffic (1 paper)RSC Advances (1 paper)mSystems (1 paper)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Chengwei Peng
19 papers receiving 383 citations
Peers
Comparison fields: 5 of 73
- Oncology 138
- Cancer Research 65
- Immunology 88
- Molecular Biology 158
- Geriatrics and Gerontology 6
Countries citing papers authored by Chengwei Peng
This map shows the geographic impact of Chengwei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengwei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengwei Peng more than expected).
Fields of papers citing papers by Chengwei Peng
This network shows the impact of papers produced by Chengwei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengwei Peng. The network helps show where Chengwei Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengwei Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 118 | |
| 2 | 2012 | 60 | |
| 3 | 2017 | 35 | |
| 4 | 2018 | 32 | |
| 5 | 2015 | 32 | |
| 6 | 2020 | 28 | |
| 7 | 2018 | 16 | |
| 8 | 2016 | 16 | |
| 9 | 2015 | 16 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2014 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2019 | 0 |
About Chengwei Peng
Chengwei Peng is a scholar working on Oncology, Molecular Biology, Surgery, Immunology and Genetics, having authored 20 papers that have together received 389 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Protein Degradation and Inhibitors (3 papers), Colorectal Cancer Treatments and Studies (3 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Melanoma and MAPK Pathways (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (138 citations), Cancer Research (65 citations), Immunology (88 citations), Molecular Biology (158 citations) and Geriatrics and Gerontology (6 citations). Chengwei Peng has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Jeffrey A. Sosman, Douglas B. Johnson, Avani Verma, James A. McNew, Joseph E. Faust, Deirdre Jill Cohen, Zhe Su, Chuanqing Zhang, Fei Ye and Shilin Zhao. Their work appears in journals such as Journal of Clinical Oncology, Gene, Traffic, RSC Advances and mSystems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.